Pfizer Affirms FY2026 Adj EPS Guidance of $2.80-$3.00 vs $2.96 Est; Affirms FY2026 Sales Guidance of $59.500B-$62.500B vs $61.418B Est

Benzinga Newsdesk www.benzinga.com Negative 46.7%

Neg 46.7% Neu 0% Pos 0%

Pfizer (NYSE:PFE) affirms FY2026 Adj EPS guidance from $2.80-$3.00 to $2.80-$3.00 vs $2.96 analyst estimate. Affirms FY2026 sales outlook from $59.500 billion-$62.500 billion to $59.500 billion-$62.500 billion vs $61.418 billion estimate.